RxDoctor Payments Data

Feyintolu Balogun

Podiatrist · Mount Prospect, ILNPI 1730567512

Payments from drug & device makers

$421in general payments, 2019–2025

Across 23 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$164
  • Amgen$138
  • Smith+Nephew$73
  • Stryker$16
  • Medimetriks Pharmaceuticals, Inc.$16
  • Integra Lifesciences Corporation$14

What the payments were for

  • Food & beverage$421100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer15$164
Amgen2$138
Smith+Nephew3$73
Stryker1$16
Medimetriks Pharmaceuticals, Inc.1$16
Integra Lifesciences Corporation1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$421 in reported general payments places this provider in the 35th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$255,715
Medicare patients
710
Services billed
4,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole269$10,898
Ammonium Lactate287$7,328
Ciclopirox13$595
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$369
Diclofenac Sodium17$353

Paid to pharmacies, not to this prescriber.

Other podiatrist in Mount Prospect

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →